More tools:Markets·Screener·Research·Chat

enVVeno Medical Corporation Common Stock (NVNO) Financial Statements

enVVeno Medical Corporation Common Stock
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SRG4B9
XNAS · usd
11.07▼ 0.42 (-3.66%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close11.49
Day's Range11.16 – 11.62
52-Week Range0.30 – 13.46
Volume4,176
Avg Volume15.0K
Share Statistics
Shares Outstanding
Employees33
ExchangeXNAS
Listed2018-05-31
Share count as of July 28, 2026
Loading Income Statement…
Key questions about enVVeno Medical Corporation Common Stock (NVNO)
What is enVVeno Medical Corporation Common Stock's Market Cap?
enVVeno Medical Corporation Common Stock's Market Cap is $7.6M, based on as-reported figures from SEC (XBRL) filings.
What is enVVeno Medical Corporation Common Stock's Enterprise Value?
enVVeno Medical Corporation Common Stock's Enterprise Value is -$13.9M, based on as-reported figures from SEC (XBRL) filings.
What is enVVeno Medical Corporation Common Stock's EV / EBITDA?
enVVeno Medical Corporation Common Stock's EV / EBITDA is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is enVVeno Medical Corporation Common Stock's Net Income (TTM)?
enVVeno Medical Corporation Common Stock's Net Income (TTM) is -$15.7M, based on as-reported figures from SEC (XBRL) filings.
What is enVVeno Medical Corporation Common Stock's EBITDA?
enVVeno Medical Corporation Common Stock's EBITDA is -$16.6M, based on as-reported figures from SEC (XBRL) filings.
What is enVVeno Medical Corporation Common Stock's Diluted EPS (TTM)?
enVVeno Medical Corporation Common Stock's Diluted EPS (TTM) is -23.03, based on as-reported figures from SEC (XBRL) filings.
What is enVVeno Medical Corporation Common Stock's Net Debt?
enVVeno Medical Corporation Common Stock's Net Debt is -$21.5M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and Development Expense
Selling, General and Administrative Expense
Loss from operations
Other income:
Non-Operating Income (Expense)
Interest Income
Total other income
Net loss
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—